FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200467235> ?p ?o ?g. }

• W4200467235 endingPage "1216" @default.
• W4200467235 startingPage "1207" @default.
• W4200467235 abstract "Purpose: The purpose of this trial was to evaluate the safety and efficacy of OC-01 (varenicline solution), a nicotinic acetylcholine receptor agonist nasal spray, on signs and symptoms of dry eye disease. Methods: A phase 2b, multicenter, randomized, double-masked, vehicle-controlled trial (ONSET-1; NCT03636061) was performed. Patients were aged 22 years or older with a physician's diagnosis of dry eye disease and previous use of artificial tears were randomized 1:1:1:1 to control (vehicle nasal spray twice daily [BID]), OC-01 0.006 mg BID, OC-01 0.03 mg BID, and OC-01 0.06 mg BID. The primary end point was the change in the anesthetized Schirmer test score from baseline to day 28 in the study eye. The secondary end points included the change in the eye dryness score from baseline to day 28. Results: One hundred eighty-two patients were randomized. After 28 days, patients who received OC-01 0.03 or 0.06 mg showed a statistically significant improvement in tear film production relative to vehicle, with least squares mean differences from vehicle of 7.7 mm [95% confidence interval, 3.8–11.7; P < 0.001] with OC-01 0.03 mg and 7.5 mm (95% confidence interval, 3.4–11.6; P < 0.001) with OC-01 0.06 mg. Patients receiving OC-01 0.03 mg showed a significant reduction in the eye dryness score by day 28 versus vehicle ( P = 0.021); those receiving the OC-01 0.06 mg dose showed a nonsignificant reduction versus vehicle. OC-01 administration was associated with sneezing (62%–84%) and cough (9%–25%); these were transient and predominantly mild in severity. Conclusions: OC-01 nasal spray administered BID at 0.03 and 0.06 mg resulted in significant improvements in signs and symptoms of dry eye disease, was well tolerated, and warrants further clinical investigation." @default.
• W4200467235 created "2021-12-31" @default.
• W4200467235 creator A5010870123 @default.
• W4200467235 creator A5013186483 @default.
• W4200467235 creator A5014454726 @default.
• W4200467235 creator A5035033005 @default.
• W4200467235 creator A5066812861 @default.
• W4200467235 creator A5070495370 @default.
• W4200467235 creator A5083670329 @default.
• W4200467235 creator A5084012626 @default.
• W4200467235 date "2021-12-21" @default.
• W4200467235 modified "2023-10-18" @default.
• W4200467235 title "ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease" @default.
• W4200467235 cites W1810293999 @default.
• W4200467235 cites W1969746337 @default.
• W4200467235 cites W2021015098 @default.
• W4200467235 cites W2021491704 @default.
• W4200467235 cites W2027975733 @default.
• W4200467235 cites W2037972678 @default.
• W4200467235 cites W2040878622 @default.
• W4200467235 cites W2048403126 @default.
• W4200467235 cites W2049280544 @default.
• W4200467235 cites W2090305797 @default.
• W4200467235 cites W2091189743 @default.
• W4200467235 cites W2093153450 @default.
• W4200467235 cites W2112526374 @default.
• W4200467235 cites W2113453721 @default.
• W4200467235 cites W2129689791 @default.
• W4200467235 cites W2141246891 @default.
• W4200467235 cites W2144919760 @default.
• W4200467235 cites W2156815499 @default.
• W4200467235 cites W2159196921 @default.
• W4200467235 cites W2176407061 @default.
• W4200467235 cites W2596272934 @default.
• W4200467235 cites W2737642784 @default.
• W4200467235 cites W2737787547 @default.
• W4200467235 cites W2758061472 @default.
• W4200467235 cites W2766445488 @default.
• W4200467235 cites W2809632906 @default.
• W4200467235 cites W2900496685 @default.
• W4200467235 cites W2933596385 @default.
• W4200467235 cites W2974823801 @default.
• W4200467235 doi "https://doi.org/10.1097/ico.0000000000002941" @default.
• W4200467235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36107843" @default.
• W4200467235 hasPublicationYear "2021" @default.
• W4200467235 type Work @default.
• W4200467235 citedByCount "16" @default.
• W4200467235 countsByYear W42004672352022 @default.
• W4200467235 countsByYear W42004672352023 @default.
• W4200467235 crossrefType "journal-article" @default.
• W4200467235 hasAuthorship W4200467235A5010870123 @default.
• W4200467235 hasAuthorship W4200467235A5013186483 @default.
• W4200467235 hasAuthorship W4200467235A5014454726 @default.
• W4200467235 hasAuthorship W4200467235A5035033005 @default.
• W4200467235 hasAuthorship W4200467235A5066812861 @default.
• W4200467235 hasAuthorship W4200467235A5070495370 @default.
• W4200467235 hasAuthorship W4200467235A5083670329 @default.
• W4200467235 hasAuthorship W4200467235A5084012626 @default.
• W4200467235 hasBestOaLocation W42004672352 @default.
• W4200467235 hasConcept C126322002 @default.
• W4200467235 hasConcept C168563851 @default.
• W4200467235 hasConcept C203092338 @default.
• W4200467235 hasConcept C42219234 @default.
• W4200467235 hasConcept C44249647 @default.
• W4200467235 hasConcept C71924100 @default.
• W4200467235 hasConceptScore W4200467235C126322002 @default.
• W4200467235 hasConceptScore W4200467235C168563851 @default.
• W4200467235 hasConceptScore W4200467235C203092338 @default.
• W4200467235 hasConceptScore W4200467235C42219234 @default.
• W4200467235 hasConceptScore W4200467235C44249647 @default.
• W4200467235 hasConceptScore W4200467235C71924100 @default.
• W4200467235 hasIssue "10" @default.
• W4200467235 hasLocation W42004672351 @default.
• W4200467235 hasLocation W42004672352 @default.
• W4200467235 hasLocation W42004672353 @default.
• W4200467235 hasOpenAccess W4200467235 @default.
• W4200467235 hasPrimaryLocation W42004672351 @default.
• W4200467235 hasRelatedWork W1966504330 @default.
• W4200467235 hasRelatedWork W1979139803 @default.
• W4200467235 hasRelatedWork W2030889776 @default.
• W4200467235 hasRelatedWork W2037631372 @default.
• W4200467235 hasRelatedWork W2070567609 @default.
• W4200467235 hasRelatedWork W2073527559 @default.
• W4200467235 hasRelatedWork W2112436308 @default.
• W4200467235 hasRelatedWork W2159000141 @default.
• W4200467235 hasRelatedWork W2355769538 @default.
• W4200467235 hasRelatedWork W2373885168 @default.
• W4200467235 hasVolume "41" @default.
• W4200467235 isParatext "false" @default.
• W4200467235 isRetracted "false" @default.
• W4200467235 workType "article" @default.